Aug 18, 2007|
That sinking feeling again!
The markets ended in negative for three out of the four trading sessions in the week, tracking weak global cues. A whole host of factors, right from yen carry trade unwinding, hedge fund redemption pressure, Foreign Institutional Investors (FIIs) selling and sub-prime concerns continued to haunt the domestic markets, resulting in benchmark indices, both BSE-Sensex as well as NSE-Nifty losing 5% during the week.
The domestic indices have been closely tracking the global markets. The week began on a positive note with BSE Sensex advancing close to 150 points, but not without some amount of volatility. A range-bound trade followed on Tuesday, when Sensex posted a marginal loss of 16 points on the back of mixed global cues. The stock markets remained closed on Wednesday on the eve of Independence Day. On Thursday, Sensex opened with a gap-down of more than 400 points as markets across the globe were gripped with selling pressure. The Sensex closed the day with a fall of 643 points, its second biggest fall in a day (in absolute terms). Selling continued on Friday, with indices losing more than 4% in the first half of the trading session. Bargain hunting at lower levels and positive cues from European markets, however, resulted in market restricting the losses to 1.5% for the day.
On the institutional activity front, between 10th and 16th August, while FIIs sold equities worth Rs 39 bn, domestic mutual funds emerged as net buyers to the tune of Rs 2 bn.
On the sectoral indices front, metal index was the worst hit, losing close to 10% during the week. Huge sell-off witnessed on the London Metal Exchange (LME) was the primary reason for the decline. IT, Bankex and PSU index were the other indices that bore the brunt of wanton sell-off, with each shedding 5% to 6%. The BSE Small Cap index was least affected, losing 2.6% during the week.
||As on August 10
||As on August 17
|BSE OIL AND GAS
Now let us have a look at some of the key stock/sector specific developments during the week:
Pharma stocks closed mixed for the week with Sun Pharma edging higher by 1%, while GSK Pharma and Cadila Helathcare lost close to 7%. As per a leading business daily, dug maker Sun Pharma has received approval from the U.S. Food and Drug Administration (USFDA) to make and market Octreotide injection. Octreotide is a generic cancer drug. While the market size of the drug has not been divulged, the said approval will boost Sun Pharma's revenues from the US market. US currently contributes 22% of the company's total revenues.
Top gainers during the week (BSE A)
In line wit the broader markets, energy stocks ended in the red with HPCL (lost 10%) and ONGC (lost 7%) leading the pack of the losers for the week. As per a leading business daily, the Prime Minister's Economic Advisory Council (EAC) has submitted a report, which says RIL's gas pricing formula is broadly correct, although it requires some minor adjustments. It mentions that the RIL's price is similar to the price at which Rawa field gas was sold recently. Moreover, market determined prices are the way to go forward as the Production Sharing Contract (PSC) under the NELP scheme expressly provides for it and is vital to attract private investment in exploration activities. The EAC however suggested that the auction conducted by RIL should be broad based and include more players than the original set of 10 participants. It also suggested that RIL should offer the entire peak production of 80 MMSCMD for auction, up from the earlier 34 MMSCMD and 10-year contracts benchmarked with Brent crude, instead of 3 year contracts. This report comes as welcome news for RIL because an earlier report submitted by the committee of secretaries (CoS) disapproved of the RIL price of $4.33/ MBTU. With the matter under the empowered group of ministers (eGoM), the EAC report bodes well for RIL.
Top losers during the week (BSE A)
As per a leading business daily, M&M will set up a utility assembly plant in Manuas, North Brazil, with local partner Bramont. The plant is expected to be commissioned by early November this year. M&M will assemble 5,000 completely knocked down kits (CKD) of Scorpio and pick-up trucks in this plant per annum. This would eventually be scaled up to its full capacity of 10,000 units a year. The move, we believe is just another example of the trend that big domestic auto companies like M&M and Tata Motors have been following of entering into lesser popular and low competition markets like the Africa and Latin America. The stock, along with its peers Tata Motors closed 4% lower.
While it is easy to be complacent in a rising stock market, market declines can be unsettling and even downright scary. Rather than getting caught in the moment, we would advise our investors to look for good quality stocks that are available at attractive prices from a long-term perspective. We believe that the India story is intact and investments made from a long-term horizon are likely to bring adequate returns.
More Views on News
Jun 10, 2017
Forty Indian investing gurus, as worthy of imitation as the legendary Peter Lynch, can help you get rich in the stock market.
Aug 19, 2017
Ever heard of Lindy Effect? Find out how you can use it to pick timeless stocks.
Aug 18, 2017
Buying the index now will hardly help make money in stocks even in ten years.
Aug 18, 2017
Donald J Trump, a wrasslin' fan, took a 'Holy Sh*t!' blow on Tuesday.
Aug 17, 2017
PersonalFN simplifies the mutual fund account statement for you.
More Views on News
Aug 7, 2017
The data tells us quite a different story from the one the government is trying to project.
Aug 10, 2017
Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.
Aug 8, 2017
Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...
Aug 12, 2017
The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.
Aug 7, 2017
Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...
Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement. LEGAL DISCLAIMER:
Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here
. The performance data quoted represents past performance and does not guarantee future results.SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: firstname.lastname@example.org. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407